Pharmacokinetics of Temozolomide in a Patient With Glioblastoma Undergoing Hemodialysis: A Short Communication

BACKGROUND: Temozolomide (TMZ) is an alkylating agent used to treat glioblastoma. However, the pharmacokinetics of TMZ to establish a treatment strategy for patients undergoing hemodialysis (HD) remain unclear. In this case report, we evaluated the pharmacokinetics and HD removal rate of TMZ in a pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Fumiaki, Irie, Kei, Fukui, Nobuyuki, Horii, Ryo, Imamura, Hirotoshi, Hirabatake, Masaki, Ikesue, Hiroaki, Muroi, Nobuyuki, Fukushima, Shoji, Sakai, Nobuyuki, Hashida, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Therapeutic Drug Monitoring 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635330/
https://www.ncbi.nlm.nih.gov/pubmed/37646650
http://dx.doi.org/10.1097/FTD.0000000000001125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635330/
https://www.ncbi.nlm.nih.gov/pubmed/37646650
http://dx.doi.org/10.1097/FTD.0000000000001125

Ejemplares similares